サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1542386

脳卒中管理の世界市場

Stroke Management

出版日
ページ情報
英文 276 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
脳卒中管理の世界市場
出版日: 2024年08月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 276 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

脳卒中管理の世界市場は2030年までに542億米ドルに達する見込み

2023年に376億米ドルと推定される脳卒中管理の世界市場は、2030年には542億米ドルに達し、分析期間2023-2030年のCAGRは5.4%で成長すると予測されます。脳卒中管理本レポートで分析したセグメントの1つである診断は、CAGR 5.1％を記録し、分析期間終了までに359億米ドルに達すると予測されます。脳卒中管理治療分野の成長率は、分析期間中CAGR 5.8％と推定されます。

米国市場は102億米ドルと推定、中国はCAGR 8.7％で成長予測

米国の脳卒中管理市場は、2023年に102億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに113億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2%と5.5%と予測されています。欧州では、ドイツがCAGR 3.3%で成長すると予測されています。

世界の脳卒中管理市場- 主要動向と促進要因のまとめ

脳卒中管理は、脳への血液供給が突然途絶え、潜在的な脳損傷と機能喪失につながる脳卒中患者の治療とリハビリを行う包括的なアプローチを包含しています。虚血性脳卒中では、血栓を溶解する組織プラスミノーゲンアクチベーター（tPA）などの血栓溶解剤の使用や、血栓を物理的に除去する血栓除去術などの外科的介入が行われます。脳内出血を伴う出血性脳卒中では、出血を抑え、脳圧を下げることに重点を置き、外科的処置を行うことが多いです。急性期治療に加えて、脳卒中管理では、抗血小板療法、抗凝固薬、血圧管理、生活習慣の改善などの二次予防戦略も行い、その後の脳卒中のリスクを減らします。

技術の進歩により、脳卒中管理の治療成績は著しく向上しました。コンピュータ断層撮影（CT）や磁気共鳴画像法（MRI）などの高度な画像診断技術の発達により、迅速かつ正確な診断が可能となり、虚血性脳卒中と出血性脳卒中の鑑別や適切な治療の指針となっています。遠隔医療も重要なツールとして登場し、急性期脳卒中治療における遠隔診察や迅速な意思決定を可能にしています。ロボット治療装置やバーチャルリアリティシステムなどのリハビリテーション技術は、脳卒中後の回復を促進し、患者がより効果的に運動能力や機能的能力を回復できるようになった。さらに、脳卒中管理における人工知能（AI）の利用は増加傾向にあり、脳卒中症状の早期発見や予測分析に基づく治療計画の最適化に役立っています。

脳卒中管理市場の成長は、いくつかの要因によってもたらされます。高齢化や高血圧、糖尿病、肥満などの生活習慣に関連する危険因子による脳卒中の発症率や有病率の増加が主な促進要因です。低侵襲手術技術や革新的な薬物療法の開発を含む医療技術の開拓は、治療結果の改善と回復時間の短縮によって市場の成長を促進しています。遠隔医療やモバイル医療アプリケーションの拡大により、特に遠隔地や農村部における脳卒中治療へのアクセスが広がっています。さらに、早期介入の重要性に対する意識の高まりと、脳卒中管理サービスの利用可能性が需要を促進しています。政府の脳卒中啓発・予防プログラムへの取り組みや資金援助も市場拡大に寄与しています。さらに、脳卒中治療プロトコルの改善や新たな治療法の開発に焦点を当てた継続的な研究開発が、市場に新たな機会を生み出しています。こうした動向が進化を続ける中、脳卒中管理市場は、技術の進歩や患者中心の包括的ケアの重視の高まりによって、持続的な成長が見込まれています。

調査対象企業の例（全45件）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • GE Healthcare
  • Heuron Co. Ltd.
  • iSchemaView, Inc.（RapidAI）
  • JIXING Pharmaceuticals
  • Johnson & Johnson MedTech
  • Koninklijke Philips N.V.
  • Medtronic
  • MicroPort Scientific Corporation
  • NeuraSignal, Inc.
  • Neurolutions, Inc.
  • NeuroSafe Medical Co., Ltd.
  • Penumbra, inc.
  • Stryker Corporation;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26673

Global Stroke Management Market to Reach US$54.2 Billion by 2030

The global market for Stroke Management estimated at US$37.6 Billion in the year 2023, is expected to reach US$54.2 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Stroke Management Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$35.9 Billion by the end of the analysis period. Growth in the Stroke Management Therapeutic segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.2 Billion While China is Forecast to Grow at 8.7% CAGR

The Stroke Management market in the U.S. is estimated at US$10.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Stroke Management Market - Key Trends and Drivers Summarized

Stroke management encompasses a comprehensive approach to treating and rehabilitating patients who have suffered a stroke, which is a sudden interruption of blood supply to the brain, leading to potential brain damage and loss of function. Immediate medical intervention is critical in stroke management and often includes the use of thrombolytic agents like tissue plasminogen activator (tPA) to dissolve clots in ischemic stroke, or surgical interventions such as thrombectomy to physically remove the clot. For hemorrhagic strokes which involve bleeding in the brain, management focuses on controlling the bleeding and reducing pressure on the brain, often through surgical procedures. In addition to acute care, stroke management also involves secondary prevention strategies, including antiplatelet therapy, anticoagulants, blood pressure management, and lifestyle modifications to reduce the risk of subsequent strokes.

Technological advancements have significantly improved stroke management outcomes. The development of advanced imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), allows for rapid and accurate diagnosis, helping to differentiate between ischemic and hemorrhagic strokes and guiding appropriate treatment. Telemedicine has also emerged as a crucial tool, enabling remote consultations and rapid decision-making in acute stroke care, especially in underserved areas. Rehabilitation technologies, including robotic therapy devices and virtual reality systems, have enhanced post-stroke recovery, allowing patients to regain mobility and functional abilities more effectively. Additionally, the use of artificial intelligence (AI) in stroke management is on the rise, aiding in the early detection of stroke symptoms and optimizing treatment plans based on predictive analytics.

The growth in the stroke management market is driven by several factors. Increasing incidence and prevalence of stroke due to aging populations and lifestyle-related risk factors such as hypertension, diabetes, and obesity are primary drivers. Advances in medical technology, including the development of minimally invasive surgical techniques and innovative drug therapies, are propelling market growth by improving treatment outcomes and reducing recovery times. The expansion of telemedicine and mobile health applications has broadened access to stroke care, particularly in remote and rural areas. Furthermore, rising awareness about the importance of early intervention and the availability of stroke management services is driving demand. Government initiatives and funding for stroke awareness and prevention programs are also contributing to market expansion. Additionally, continuous research and development efforts focused on improving stroke care protocols and developing new therapeutic options are generating new opportunities in the market. As these trends continue to evolve, the stroke management market is poised for sustained growth, driven by technological advancements and an increasing emphasis on comprehensive, patient-centered care.

Select Competitors (Total 45 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • GE Healthcare
  • Heuron Co. Ltd.
  • iSchemaView, Inc. (RapidAI)
  • JIXING Pharmaceuticals
  • Johnson & Johnson MedTech
  • Koninklijke Philips N.V.
  • Medtronic
  • MicroPort Scientific Corporation
  • NeuraSignal, Inc.
  • Neurolutions, Inc.
  • NeuroSafe Medical Co., Ltd.
  • Penumbra, inc.
  • Stryker Corporation;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Stroke Management - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Stroke Propels Demand for Management Solutions
    • Technological Advancements in Imaging Techniques Strengthen Diagnostic Accuracy
    • Expansion of Telemedicine Broadens Access to Acute Stroke Care
    • Development of Minimally Invasive Surgical Techniques Drives Market Growth
    • Innovative Drug Therapies Enhance Treatment Outcomes and Spur Market Expansion
    • Rising Prevalence of Lifestyle-Related Risk Factors Expands Addressable Market Opportunity
    • Adoption of AI and Predictive Analytics in Early Stroke Detection Throws Spotlight on Advanced Technologies
    • Integration of Mobile Health Applications in Stroke Management Sustains Market Growth
    • Enhanced Rehabilitation Technologies Propel Post-Stroke Recovery Market
    • Expanding Healthcare Infrastructure in Emerging Markets Drives Adoption
    • Improved Secondary Prevention Strategies Drive Long-Term Market Growth
    • Growing Use of Thrombectomy Procedures Enhances Acute Stroke Management
    • Advances in Robotic Therapy Devices Expand Rehabilitation Market
    • Increasing Use of Wearable Devices for Monitoring Post-Stroke Patients Generates Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Stroke Management Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Stroke Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostics Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostics Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnostics Type by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Therapeutic Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Therapeutic Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Therapeutic Type by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ischemic Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ischemic Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ischemic Stroke Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hemorrhagic Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hemorrhagic Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hemorrhagic Stroke Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • JAPAN
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • CHINA
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • EUROPE
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Stroke Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • FRANCE
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • GERMANY
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Stroke Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • INDIA
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: India 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Stroke Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Stroke Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
  • AFRICA
    • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030

IV. COMPETITION